Physician Assistant · Norfolk, VA
NPI
1144740614
Since 2017
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
825 Fairfax Ave Ste 572
Norfolk, VA, 23507
Phone (757) 446-8999
Medicare paid, 2024
$12K
187 services
Medicare patients, 2024
85
Average age 67
Drug cost, 2024
$7.0M
2,141 prescriptions
Company payments, 2025
$23K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hillary M Hartung was code 99214 (office e&m - established), 85 times for 51 patients. In total Hillary M Hartung billed 187 services in 21 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 85 | 51 | $56.33 | $4,788 |
| 99308 SNF E&M | Facility | 30 | 11 | $48.39 | $1,452 |
| 99306 SNF E&M | Facility | 14 | 12 | $118.12 | $1,654 |
By year: 2022 $12K for 217 services; 2023 $14K for 212 services; 2024 $12K for 187 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hillary M Hartung prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 719 prescriptions and refills. In total Hillary M Hartung wrote 2,141 Medicare prescriptions that cost $7.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 719 | 735 | 88 | $3.0M |
| Dovato Dolutegravir Sodium/Lamivudine | 229 | 229 | 26 | $674K |
| Tivicay Dolutegravir Sodium | 196 | 208 | 23 | $484K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 174 | 186 | 19 | $707K |
| Descovy Emtricitabine/Tenofov Alafenam | 151 | 159 | 17 | $356K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 148 | 148 | 14 | $540K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 116 | 116 | 13 | $533K |
| Juluca Dolutegravir/Rilpivirine | 81 | 81 | Under 11 | $281K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 46 | 46 | Under 11 | $178K |
| Ritonavir Generic | 30 | 44 | Under 11 | $4,744 |
| Isentress Raltegravir Potassium | 24 | 24 | Under 11 | $45K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 24 | 26 | Under 11 | $123 |
| Prezista Darunavir | 23 | 23 | Under 11 | $49K |
| Pifeltro Doravirine | 21 | 33 | Under 11 | $54K |
| Lamivudine Generic | 21 | 22 | Under 11 | $3,404 |
Brand drugs: 1,956 claims; generic drugs: 185 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hillary M Hartung $23K ($23K in general payments such as food, travel and fees) from 2 companies. The largest payer was ViiV Healthcare Company with $13K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.